PharmacyCodes



Ergoloid mesylate en es it fr

Ergoloid mesylate Brand names, Ergoloid mesylate Analogs

Ergoloid mesylate Brand Names Mixture

  • No information avaliable

Ergoloid mesylate Chemical_Formula

C33H45N5O5

Ergoloid mesylate RX_link

No information avaliable

Ergoloid mesylate fda sheet

Ergoloid mesylate msds (material safety sheet)

Ergoloid mesylate Synthesis Reference

No information avaliable

Ergoloid mesylate Molecular Weight

591.741 g/mol

Ergoloid mesylate Melting Point

No information avaliable

Ergoloid mesylate H2O Solubility

No information avaliable

Ergoloid mesylate State

Solid

Ergoloid mesylate LogP

2.615

Ergoloid mesylate Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Ergoloid mesylate Indication

For use as an adjunct therapy for patients with dementia

Ergoloid mesylate Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Ergoloid mesylate Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Ergoloid mesylate side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Ergoloid mesylate Patient Information

No information avaliable

Ergoloid mesylate Organisms Affected

Humans and other mammals